Growth is driven by the rising prevalence of diabetes among the elderly, necessitating efficient insulin delivery solutions ...

This trend directly correlates with an increased demand for insulin delivery devices, particularly pen needles, due to their ease of use and minimized pain compared to traditional syringes.

Mizuho initiated coverage of Embecta (EMBC) with a Neutral rating and $15 price target The firm says its rating balances the company’s ...

Incretin mimetics administered by auto-injectors or pens enable significant weight reduction and offer an important means of ...

The global injectable drug delivery devices market size was estimated at USD 519 billion in 2024 and is predicted to reach ...

KLP Kapitalforvaltning AS bought a new stake in Embecta Corp. (NASDAQ:EMBC – Free Report) during the 4th quarter, according ...

This applies to injecting insulin with a syringe, prefilled insulin pen needle, or if you’re using an insulin pump infusion site on the body. Try not to use the same exact place on your body ...

Assad, unleashed a Sarin gas strike on the suburbs of Damascus in 2013, killing at least 1,500. Now, the survivors want ...

Needles in pens are often smaller than those in syringes. Not all types of insulin can be used with a pen. Pens can be more expensive than syringes and are sometimes not covered by insurance.

This market research report provides an in-depth analysis of the Injectable Drug Delivery Market, projecting significant ...

Among these are needle device-based treatments that have ... and Auvi-Q® marketed by Kaleo Inc. and syringe device Symjepi® marketed by US Worldmeds. In August 2024, ARS Pharmaceuticals, Inc ...